Search
for

    Research 10 of 214

    1. Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials SKIN The Journal of Cutaneous Medicine · 2025
    2. Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy Skin · 2023
    3. Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience Journal of Dermatological Treatment · 2023 · 21 citations
    4. Baricitinib for the Treatment of Alopecia Areata Drugs · 2023 · 6 citations
    5. Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study Journal of Cutaneous Immunology and Allergy · 2025
    6. 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity Journal of Investigative Dermatology · 2024
    7. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata Drug Design Development and Therapy · 2022 · 49 citations
    8. Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study Dermatologic Therapy · 2017 · 39 citations
    9. Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study Archives of Dermatological Research · 2024 · 20 citations
    10. Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study Journal of the European Academy of Dermatology and Venereology · 2025 · 15 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →